Search Results - Robert Peter Gale

Robert Peter Gale

|occupation = Physician, medical researcher |alma_mater = Hobart and William Smith Colleges
State University of New York
University of California }} Robert Peter Gale (born October 11, 1945) is an American physician and medical researcher. He is known for research in leukemia and other bone marrow disorders (such as aplastic anemia). Provided by Wikipedia
Refine Results
  1. 1

    MISSION TO MARS: RADIATION RISKS FROM INTER-PLANETARY TRAVEL by Robert Peter Gale

    Published in Hematology, Transfusion and Cell Therapy (2025-07-01)
    Get full text
    Article


  2. 2

    Hematopoietic cell transplants for acute leukemias by Robert Peter Gale

    Published in Haematologica (2025-04-01)
    Get full text
    Article


  3. 3

    Will immune therapy cure acute myeloid leukemia? by Robert Peter Gale

    Published in Hematology, Transfusion and Cell Therapy (2022-10-01)
    Get full text
    Article


  4. 4

    Daratumumab in children with advanced idiopathic thrombocytopenic purpura by Robert Peter Gale

    Published in Blood Science (2025-09-01)
    Get full text
    Article


  5. 5

    Daratumumab in relapsed or refractory immune thrombocytopenic purpura by Ciprian Tomuleasa, Robert Peter Gale

    Published in Blood Science (2025-12-01)
    Get full text
    Article


  6. 6

    The Gordian knot: ruxolitinib or transplants for high-risk myelofibrosis by Robert Peter Gale, Giovanni Barosi

    Published in Haematologica (2024-07-01)
    Get full text
    Article


  7. 7

    A Critical Reappraisal of Gastrointestinal Complications of Allogeneic Bone Marrow Transplantation by Gary J. Schiller, Robert Peter Gale

    Published in Cell Transplantation (1992-03-01)
    Get full text
    Article


  8. 8

    Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia? by Giuseppe Saglio, Carmen Fava, Robert Peter Gale

    Published in Haematologica (2019-05-01)
    Get full text
    Article


  9. 9

    COST-EFFECTIVENESS OF POST-AUTOTRANSPLANT LENALIDOMIDE IN PERSONS WITH MULTIPLE MYELOMA. by Monia Marchetti, Robert Peter Gale, Giovanni Barosi

    Get full text
    Article


  10. 10

    COST-EFFECTIVENESS OF POST-AUTOTRANSPLANT LENALIDOMIDE IN PERSONS WITH MULTIPLE MYELOMA. by Monia Marchetti, Robert Peter Gale, Giovanni Barosi

    Get full text
    Article


  11. 11

    Predicting survival of persons with newly-diagnosed multiple myeloma by Limei Zhang, Yun Wang, Robert Peter Gale, Yang Liang

    Published in Cancer Cell International (2025-08-01)
    Get full text
    Article


  12. 12

    Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time? by Hillard M. Lazarus, Carolyn E. Ragsdale, Robert Peter Gale, Gary H. Lyman

    Published in Frontiers in Immunology (2021-08-01)
    Get full text
    Article


  13. 13

    A Nomogram Built on Clinical Factors and CT Attenuation Scores for Predicting Treatment Response of Acute Myeloid Leukemia Patients by Linna Liu, Wenzheng Lu, Li Xiong, Han Qi, Robert Peter Gale, Bin Yin

    Published in Biomedicines (2025-01-01)
    Get full text
    Article


  14. 14

    Mapping the cancer vaccine landscape by Huan Li, Fang Hu, Yang Liang, Xiaojun Huang, Weiran Lv, Mengjing Li, Robert Peter Gale

    Published in Journal for ImmunoTherapy of Cancer (2025-09-01)
    Get full text
    Article


  15. 15

    Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression? by Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Adriana Carolei, Margherita Massa, Robert Peter Gale, Vittorio Rosti

    Published in Blood Cancer Journal (2024-01-01)
    Get full text
    Article


  16. 16

    Phase II study of pegaspargase, etoposide, gemcitabine (PEG) followed by involved-field radiation therapy in early-stage extranodal natural killer/T-cell lymphoma by Demei Feng, Zhimin Yan, Bibo Fu, Shenrui Bai, Lewei Zhu, Robert Peter Gale, Zhongjun Xia, Yang Liang, Hua Wang

    Published in Hematology (2024-12-01)
    Get full text
    Article


  17. 17

    VEGFA rs3025039 is associated with phenotype severity of myelofibrosis‐type megakaryocyte dysplasia by Giovanni Barosi, Paolo Catarsi, Rita Campanelli, Margherita Massa, Adriana Carolei, Carlotta Abbà, Annalisa deSilvestri, Robert Peter Gale, Vittorio Rosti

    Published in eJHaem (2023-08-01)
    Get full text
    Article


  18. 18

    Multi-Walled Carbon Nanotubes Accelerate Leukaemia Development in a Mouse Model by Qingqing Wang, Jingdan Han, Mujia Wei, Huikai Miao, Min Zhang, Biao Wu, Yao Chen, Yanwen Zheng, Robert Peter Gale, Bin Yin

    Published in Toxics (2024-09-01)
    Get full text
    Article


  19. 19

    ASXL2 mutated myelodysplastic syndrome in a novel germline G6b variant by Shiqiang Qu, Donglei Zhang, Zefeng Xu, Yujiao Jia, Tiejun Qin, Lijuan Pan, Wenyu Cai, Yudi Zhang, Robert Peter Gale, Zhijian Xiao

    Published in Leukemia Research Reports (2022-01-01)
    Get full text
    Article


  20. 20

    Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis by Xiaofan Sun, Yue Li, Juan Du, Fangshu Liu, Caiping Wu, Weihao Xiao, Guopan Yu, Xiaowei Chen, Robert Peter Gale, Hui Zeng

    Published in Nature Communications (2025-02-01)
    Get full text
    Article


Search Tools: